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1. Introduction 
Whilst the reactions of the citric acid cycle [l] and 
related pathways are well established, the manner in 
which the flux through the pathway is regulated in 
different tissues remains an area of active research 
and debate. The primary focus during the last decade 
has been on enzyme mechanisms, the intracellular 
compartmentation of enzymes and intermediates of 
the cycle, and on the interrelations with the specific 
anion translocating systems of the inner mitochon- 
drial membrane. A number of recent reviews have 
been concerned with relating citric acid cycle activity 
to the regulation of carbohydrate and fatty acid oxi- 
dation [2-41, metabolite transport across the mito- 
chondrial membrane for gluconeogenesis, ureogenesis 
and fatty acid synthesis [5-l 11, cellular energy 
metabolism [12-l 61, as well as with more specialized 
topics such as pyruvate [ 17,181 and ethanol [ 191 
metabolism. The concept that the enzymes of the 
citric acid cycle are organized as a functional multi- 
enzyme complex has also been advocated [20,21]. 
Until recently it has been generally’accepted that 
turnover of the citric acid cycle per se is regulated at 
the dehydrogenase level primarily by the mitochon- 
drial NAD’/NADH ratio. This ratio is linked to the * 
mitochondrial ATP/ADP ratio and ultimately to the 
cytosolic phosphorylation potential, which is a pri- 
mary factor in the control of tissue respiration. How- 
ever, since the different NAD’substrate dehydro- 
genases are regulated with different sensitivities by 
the NAD’INADH ratio, the absolute NAD’ redox 
potential for a given flux depends on the concentra- 
tion and nature of the substrate supply to the mito- 
chondria. On the other hand, the anaplerotic func- 
tions of the citric acid cycle are regulated by ancillary 
enzymes such as pyruvate dehydrogenase, pyruvate 
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carboxylase, carbamyl phosphate synthetase and glu- 
tamate dehydrogenase, which affect substrate deliv- 
ery of cycle intermediates and ultimately the rate of 
production of end products such as glucose, fatty 
acids and urea. More recent observations have sug- 
gested that the activities of several citric acid cycle 
enzymes can be markedly influenced by low [Ca”‘] 
[22]. This observation combined with the finding 
that the mitochondrial calcium content is hormonally 
regulated [23-251, has prompted the speculation 
that Ca2+ could also regulate the activity of the citric 
acid cycle. In this review, we provide a brief synopsis 
of feedback regulation in the citric acid cycle and 
examine the possibility of Ca2+ regulation in the con- 
text of current knowledge concerning the regulation 
of Ca2+ uptake and release by mitochondria and the 
likely range of intramitochondrial free [Ca”]. 
2. Importance of regulation of the citric acid cycle 
The citric acid cycle provides reducing equivalents 
to the electron-transport chain and also, via ancillary 
reactions, provides substrates for biosynthetic reac- 
tions in the cytosol. The relative importance of these 
roles in the overall metabolism of the tissue will thus 
vary with the particular organ and the dietary status 
of the animal. The basic reactions of the citric acid 
cycle and its interactions with ancillary functions such 
as gluconeogenesis and ureogenesis, which occur only 
in liver, are depicted schematically in fig.1 without 
reference to compartmentation of reactions between 
the cytosol and mitochondria. A particularly striking 
feature of the regulation of the citric acid cycle is its 
flexibility by which flux rapidly becomes adjusted to 
the metabolic demands of the tissue and the nature of 
the substrate mixture delivered to the organ. In heart 
and to a lesser extent in brain, the major role of the 
citric acid cycle is to accomplish oxidation of the 
acetyl moiety of acetyl-CoA to COZ and water, and 
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Fig.1. Schematic representatiqn of the citric acid cycle show- 
ing interactions with major metabolic pathways in liver. 
intermediates of the cycle are used catalytically such 
that, except for brief intervals during transition states, 
the individual enzymes behaves as a functional unit 
and cycle flux is proportional to oxygen consumption. 
Cardiac muscle is able to oxidize a wide variety 
of substrates, including carbohydrate, fatty acids, 
ketone bodies and to a lesser extent amino acids [4]. 
Oxidation of these substrates, and particularly glu- 
cose, is subject to a variety of controls mediated by 
intracellular factors such as the ATP/ADP ratio, Pi, 
pH, NAD+/NADH ratio, as well as extracellular hor- 
monal influences and the permeability characteristics 
of the plasma membrane. Consequently, the various 
substrates differ in their relative efficacy as respira- 
tory fuels, which is determined ultimately by the 
maximum rate at which they can deliver acetyl-CoA 
to the citric acid cycle. Thus, when individual sub- 
strates are provided to the isolated perfused heart as 
sole exogenous respiratory fuel, and the heart is chal- 
lenged by an increase of work load, respiration and 
hence the maximum work output reaches a limit, 
which varies with the nature of the substrate and is 
determined by the rate of acetyl-CoA generation 
[26]. Conversely, when acetyl-CoA utilization is 
below the saturation limit for different substrates, 
tissue acetyl-CoA and cycle intermediate levels vary 
over a wide range dependent on the substrate source 
with glucose as substrate, acetyl-CoA levels may be 
lo-fold lower than with fatty acid as substrate for the 
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same citric acid cycle flux [27-291. Thus, it is clear 
that citric acid cycle activity is not regulated simply 
by the mitochondrial acetyl-CoA concentration. 
The citric acid cycle, excluding pyruvate dehydro- 
genase which will be discussed later, contains three 
non-equilibrium enzyme steps, namely citrate syn- 
thase, NAD+-linked isocitrate dehydrogenase and 
a-ketoglutarate dehydrogenase. From studies with 
isolated mitochondria [30-341, together with 
metabolite analyses of hearts perfused under differ- 
ent conditions of substrate supply and work loads 
[27,29,35-381, an overall concept of regulation has 
been formulated (reviewed [4,6,15,16,39]). The key 
energy-linked regulatory factor determining citric 
acid cycle flux appears to be the mitochondrial free 
NAD+/NADH ratio, which interacts at a number of 
enzyme steps. The pyridine nucleotide redox state 
interacts with other intramitochondrial parameters 
such as the ATP/ADP, GTP/GDP, and NADP+/ 
NADPH, acetyl-CoA/CoASH, succinyl-CoA/CoASH, 
acetyl-CoA/succinyl-CoA and citrate/oxaloacetate 
ratios, in a manner which is dependent on the abso- 
lute concentrations of the cycle intermediates. Clearly 
the multiple and changing demands of tissue respira- 
tion and varied metabolic functions necessitate a pre- 
cise, albeit complex, regulation of the individual 
enymes of the citric acid cycle. 
3. Coordination of cycle flux by feedback regulation 
Citrate synthase activity is regulated directly by 
accessible pools of either of its two substrates oxalo- 
acetate and acetyl-CoA. Oxaloacetate can be trans- 
ported across the mitochondrial membrane by either 
the dicarboxylate [40] or at-ketoglutarate [41] trans- 
locator, but the unfavourable kinetic constants in 
conjunction with the low free oxaloacetate concen- 
tration in the mitochondria suggest hat a direct com- 
munication between the cytosolic and mitochondrial 
pools of oxaloacetate is not an important factor in 
regulation of cycle activity. The apparent Km of 
citrate synthase for oxaloacetate at saturating acetyl- 
CoA concentrations is l-5 I.IM [20,42,43]. The mito- 
chondrial oxaloacetate concentration is expected to 
be determined by the malate concentration and the 
NAD’/NADH ratio. Calculations of the oxaloacetate 
concentration of isolated heart mitochondria assum- 
ing equilibrium of malate dehydrogenase yielded 
0.36 PM, while the value calculated from the mea- 
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sured concentrations of aspartate aminotransferase 
reactants was 10 MM [34]. In these experiments, the 
measured mitochondrial oxaloacetate concentration 
for state 4 conditions was 36 PM. A similar problem 
arises from considerations of the oxaloacetate con- 
centration in liver mitochondria [44]. It is generally 
accepted that mitochondrial oxaloacetate must be 
compartmented by protein binding, but it remains unre- 
solved whether malate dehydrogenase and citrate syn- 
thase are both in equilibrium with the free mitochon- 
drial oxaloacetate concentration, or whether either 
enzyme is displaced from equilibrium [4,6,16,34,45]. 
A concerted interaction between malate dehydro- 
genase and citrate synthase, which in effect results in 
substrate channeling, has been suggested [45]. Since 
citrate synthase in intact mitochondria or tissues 
operates well below its Vmax, and flux is responsive 
to changes of the NAD’/NADH ratio, it is concluded 
that the oxaloacetate concentration available to citrate 
synthase is in the regulatory Km region [3 1,46-491. 
Flux through citrate synthase in intact mitochondria is 
also effectively regulated by changes of acetyl-CoA 
concentration [50]. Kinetic studies with isolated 
citrate synthase show that the apparent Km for acetyl- 
CoA is S-10 MM [20,42,43]. This is an order of mag- 
nitude lower than the range of acetyl-CoA concentra- 
tions found in isolated mitochondria [31], or calcu- 
lated from total tissue contents assuming that most of 
the acetyl-CoA is mitochondrial [51]. The activity of 
citrate synthase is inhibited by physiological concen- 
trations of NADH, NADPH and succinyl-CoA (com- 
petitive with acetyl-CoA and noncompetitive with 
oxaloacetate, [42,52]), which have the eftect of 
increasing the apparent Km for acetyl-CoA. Succinyl- 
CoA inhibition via the GTP/GDP ratio and succinate 
thiokinase provides an energy-dependent link between 
product inhibition of a-ketoglutarate dehydrogenase 
by succinyl-CoA and a-ketoglutarate generation 
through citrate synthase [6]. 
Regulation of acetyl-CoA entry into the citric acid 
cycle is however, not achieved solely through effects 
on citrate synthase activity, but rather by a concerted 
regulation of both citrate synthase and NAD+-linked 
isocitrate dehydrogenase, in an analogous manner to 
the coordinated regulation between hexokinase and 
phosphofructokinase mediated by the product inhibi- 
tion of hexokinase by glucose 6-phosphate [53]. 
Thus, citrate synthase is inhibited by citrate com- 
petitively with oxaloacetate with Ki 1.6 mM which is 
well within the range of intramitochondrial citrate 
concentrations [31]. The mitochondrial citrate con- 
centration in turn is dependent on the activity of 
NAD’-linked isocitrate dehydrogenase, which is 
strongly regulated by the NAD’/NADH ratio as a 
result of product inhibition by NADH [54,55]. The 
effect of this interaction is to allow an increase of 
flux despite a fall of the isocitrate concentration. 
During transitions from the resting to active state in 
isolated heart mitochondria (state 4-3 transition) or 
with an increased work load in perfused rat hearts, 
conditions associated with an oxidation of the mito- 
chondrial pyridine nucleotides, a primary inter- 
action at isocitrate dehydrogenase was identified 
by an immediate fall of citrate or isocitrate levels 
[30,31,35,56,57]. A fall of the citrate concentration 
results in a lowering of the apparent Km of citrate 
synthase for oxaloacetate, which together with the 
direct effect on oxaloacetate levels as a consequence 
of the adjustment of the malate/oxaloacetate ratio by 
interaction of the increased NAD+/NADH ratio with 
malate dehydrogenase, permits increased flux through 
citrate synthase. 
In heart, an obligatory linkage of flux through 
citrate synthase to flux through isocitrate dehydro- 
genase is ensured by the low activity of the mito- 
chondrial tricarboxylate carrier [30,47,58]. NAD+- 
linked isocitrate dehydrogenase is also allosterically 
activated by ADP in a Mg2+-dependent manner [59], 
which together with an ATP inhibition of citrate syn- 
thase provided the basis for the concept of a direct 
adenine nucleotide regulation of citric acid cycle 
activity [50,60]. However, it is now fairly certain that 
changes of the mitochondrial ATP/ADP ratio are less 
important as a regulatory factor in mammalian mito- 
chondria than changes of the NAD+/NADH ratio for 
the following reasons: 
(i) As discussed in the following section, it is evident 
that over the physiologically relevant range of 
extramitochondrial ATP/ADP ratios associated 
with active mitochondrial respiration in the 
intact tissue, changes of the intramitochondrial 
ATP/ADP ratio are very small. 
(ii) The postulate of ATP inhibition of citrate syn- 
thase is no longer considered valid, primarily 
because MgATP, the predominant form of ATP 
in mitochondria, is not inhibitory [6,16]. 
(iii) Studies with isolated heart mitochondria [30] 
and a soluble fraction from liver mitochondria 
[61] haveindicated that regulation of flux through 
isocitrate dehydrogenase by the ATP/ADP 
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ratio is quantitatively much less than by the 
NAD+/NADH ratio. 
In contrast, the elegant studies by Hansford and col- 
leagues (reviewed [ 161) have shown very convincingly 
that regulation of the citric acid cycle in insect flight 
muscle is achieved primarily by ADP activation of 
isocitrate dehydrogenase rather than by changes of 
the NAD+/NADH ratio, which in this specialized tis- 
sue falls rather than rise! with increased respiratory 
activity. 
Mitochondria also contain an NADP*-dependent 
isocitrate dehydrogenase, and various authors have 
discussed its participation in citric acid cycle turnover 
[4,10]. Increased flux through the NADP+-linked iso- 
citrate dehydrogenase has been shown in isolated rat 
liver mitochondria after addition of uncoupling 
agents [62,63]. However, under energized conditions, 
the NADP*/NADPH ratio is maintained very low 
because of the high activity of the energy-linked 
transhydrogenase. Furthermore, the activity of 
NADP* regenerating reactions such as glutamate 
dehydrogenase is low in heart, so that flux through 
NADP+-linked isocitrate dehydrogenase probably 
contributes little to normal citric acid cycle flux in 
tissues with low biosynthetic functions. In liver, on 
the other hand, NADP+-linked isocitrate dehydro- 
genase has an important role: 
(i) It supplies NADPH for the reductive amination 
of ammonia and a-ketoglutarate to glutamate via 
glutamate dehydrogenase [64,65]; and 
(ii) It participates with cytosolic NADP+-linked iso- 
citrate dehydrogenase in an isocitrate (citrate)- 
cr-ketoglutarate cycle which equilibrates the 
cytosolic and mitochondrial NADP’ redox poten- 
tials across the mitochondrial membrane [44,6$]. 
This latter cycle can also be used to provide a net 
transport of NADPH reducing equivalents from mito- 
chondria to the cytosol in response to a stimulation 
of cytosolic NADPH utilizing enzymes [67]. 
The mitochondrial NAD’/NADH ratio interacts 
with the citric acid cycle at a third enzyme step, 
namely a-ketoglutarate dehydrogenase. As first noted 
by Garland [68], cw-ketoglutarate d hydrogenase is 
inhibited by its products, NADH and succinyl-CoA. 
Further studies with purified enzyme from pig heart 
[33] showed that inhibition by succinyl-CoA was 
competitive with respect to CoASH (Ki 6.9 PM com- 
pared with a Ki for CoASH of 2.7 MM) and was inde- 
pendent of the NAD+/NADH ratio. Inhibition by 
NADH was non-competitive with respect to both 
NAD’ and a-ketoglutarate, and was observed at both 
high and low succinyl-CoA levels. Independent or 
concurrent regulation of flux through cr-ketoglutarate 
dehydrogenase by the succinyl-CoA/CoASH and 
NAD+/NADH ratios has been described in experi- 
ments with both heart [30-321 and liver [33,69,70] 
mitochondria incubated under a variety of metabolic 
conditions (reviewed [6,16]). However, the inhibi- 
tory effects of high succinyl-CoA/CoASH or NADH/ 
NAD+ ratios can be overcome by an increase of the 
intramitochondrial a-ketoglutarate concentration, 
which appears to be in a favourable region for kinetic 
control of cr-ketoglutarate dehydrogenase despite 
the fact that the apparent Km for cY-ketoglutarate 
observed with intact mitochondria is much higher 
than that observed for the isolated enzyme [32]. 
Recently a direct inhibitory effect of a high ATP/ 
ADP ratio has been observed with purified cr-keto- 
glutarate dehydrogenase [22,71] although whether 
this effect is important in isolated mitochondria 
remains to be ascertained. On the other hand, a rela- 
tionship between the intramitochondrial ATP/ADP 
ratio and the succinyl-CoA/CoASH ratio (via the 
GTP/GDP ratio) has been observed in isolated liver 
and heart mitochondria [32,33]. This interaction, 
mediated through nucleotide diphosphate kinase and 
succinate thiokinase, allows the succinyl-CoA/CoASH 
ratio to be regulated independently of the NAD+/ 
NADH ratio, and may account for the fact that 
changes of the NAD’/NADH ratio do not always cor- 
relate with changes of flux through a-ketoglutarate 
dehydrogenase [72]. 
Several points concerning regulation of a-keto- 
glutarate dehydrogenase are worth stressing since it 
not only is the enzyme important in the coordination 
of citric acid cycle activity, but cr-ketoglutarate is a 
common intermediate among different pathways. 
(i) In transition states the activity of cr-ketoglutarate 
dehydrogenase relative to that of isocitrate 
dehydrogenase is an important factor in permit- 
ting a redistribution of carbon between cycle 
intermediates in the mitochondria. The substrate 
concentrations of the individual enzymes thereby 
become adjusted to the new enzyme activity 
states with achievement of a common flux. Thus, 
increased flux is usually associated with decreased 
citrate and increased malate, and a consequent 
rise of the oxaloacetate concentration and ensu- 
ing substrate activation of citrate synthase [35]. 
(ii) An additional feedback effect is exerted at citrate 
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synthase by the inhibitory effect of succinylCoA, 
which is most effective at high NAD+/NADH 
ratios, low acetyl-CoA concentrations [3 1.1 and 
relatively high respiratory rates [30]. Further 
discussion of the role of the acetyl-CoA/succinyl- 
CoA ratio in the regulation of citric acid cycle 
activity is given in a review by Hansford [ 161. 
(iii) Since mitochondrial oxaloacetate and a-keto- 
glutarate are in equilibrium with the much larger 
pool sizes of aspartate and glutamate, differences 
of flux through citrate synthase and a-keto- 
glutarate dehydrogenase, in conjuction with 
transaminase activity, can lead to a net depletion 
or repletion of cycle intermediates [38]. A read- 
justment of enzyme activities in response to 
increased levels of acetyl-CoA from acetate [27] 
or NADH delivery from glycolysis [38] without 
appreciable changes of overall ATP generation in 
perfused rat heart is accompanied by increases in 
the total pool size of all cycle intermediates, and 
is associated with transient unequal flux through 
the span from acetyl-CoA to ol-ketoglutarate 
compared with the span from a-ketoglutarate to 
oxaloacetate (reviewed [4,39]). Since the citric 
acid cycle per se does not permit net entry or 
removal of intermediates, this is achieved in ske- 
letal or cardiac muscle by the combined action of 
alanine and aspartate aminotransferases by NAD’- 
and NADP’-linked malic enzymes, and by pro- 
pionate and branched chain amino acid metab- 
olism (e.g. [73,74]). 
(iv) During transfer of reducing equivalents from the 
cytosol to the mitochondria by the malate- ’ 
aspartate cycle, a-ketoglutarate is formed in the 
mitochondrial matrix not only from isocitrate 
dehydrogenase but also as a product of transami- 
nation between oxaloacetate and glutamate. 
There is thus a competition for a-ketoglutarate 
between further oxidation in the citric acid cycle and 
efflux to the cytosol in exchange with malate on the 
o-ketoglutarate carrier [39]. Steady-state fluxes 
through the malate-aspartate and citric acid cycles 
are achieved :
(i) By adjustment of the mitochondrial a-keto- 
glutarate concentration, so that flux through 
cu-ketoglutarate dehydrogenase, at its prevailing 
activity state determined by product inhibition 
becomes equal to that of citrate synthase and iso- 
citrate dehydrogenase; and 
(ii) By adjustment of the cytosolic malate concentra- 
tion (an activator) to meet the kinetic require- 
ments of the malate:a-ketoglutarate translocator 
[391. 
The experiments upon which these conclusions are 
based [38] have been relatively successfully modelled 
by computer simulation techniques [75]. 
4. Interrelations between the respiratory chain and 
the citric acid cycle 
According to the generally accepted chemiosmotic 
coupling hypothesis of Mitchell [76,77], the respira- 
tory carriers are arranged spatially in the inner mito- 
chondrial membrane such that electron transport is 
associated with proton efflux from the mitochondrial 
matrix and the generation of a proton electrochemi- 
cal gradient (A&,+). This establishes an electrical 
potential, A$ (negative inside), and a pH gradient 
(alkaline inside) across the inner mitochondrial mem- 
brane, with the overall protonmotive force (Ap) being 
defined by the relationship: 
Ap = A&+/F = AI/I - (2.3 RT/F) ApH 
Free energy is released in the oxidation-reduction reac- 
tions of the electron-transport chain by movement of 
reducing equivalents or electrons from a high electro- 
chemical pressure (negative redox potential) to a 
lower electrochemical pressure (more positive redox 
potential). The proton electrochemical gradient pro- 
vides a back pressure to the driving force produced by 
the oxidation-reduction reactions of electron trans- 
port, and thus regulates forward electron transport 
and the respiratory rate. Electron flow occurs when a 
proton circuit is established by inward proton trans- 
port. During ATP synthesis, inward movement of 
protons is channeled through the vectorial ATPase, 
which spans the mitochondrial inner membrane, and 
ATP is formed from ADP and Pi in the matrix space. 
ATP is subsequently transported out of the mito- 
chondria in exchange for ADP on the adenine nucleo- 
tide translocator during ADP-stimulated respiration 
(state 3), and respiration slows to the controlled 
state 4 rate when the extramitochondrial adenine 
nucleotide phosphorylation potential achieves equi- 
librium with the protonmotive force. Energy invested 
in the maintenance of A&+ can also be used to sup- 
port an electrophoretic influx of cations such as Ca2+, 
or net efflux of negative charge associated with 
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anion transport, as in the electrogenic exchange of 
ADP3- with ATP4-. Energy is conserved during ion- 
transport, but respiration is not associated with ATP 
synthesis. 
When mitochondria are incubated in the presence 
of oxidizable substrates, adenine nucleotides, phos- 
phate and oxygen, the energetically useful redox 
potential difference from NADH to oxygen (A&) 
achieves thermodynamic equilibrium with a high 
cytosolic ATP phosphorylation potential, and elec- 
tron transport flux is ideally zero. Because of the 
obligatory electrogenic nature of the adenine nucleo- 
tide translocator [78,79], the extramitochondrial 
ATP/ADP ratio is greater than that of the mitochon- 
drial matrix according to the relationship: 
2.3 RT 
A$=- F log 
(ATP/ADP), 
(ATP/ADP), 
With increased respiration, this equilibrium is dis- 
turbed by a fall of the cytosolic phosphorylation 
potential, with flux being proportional to the devia- 
tion from equilibrium between the driving force 
of the oxidation-reduction reactions and the extra- 
mitochondrial phosphorylation potential [ 13,15,80]. 
Since (ATP/ADP), falls proportionately much less 
than (ATP/ADP),, the adenine nucleotide trans- 
locase deviates from equilibrium with A$ during 
state 4-3 transitions with isolated mitochondria 
[81-831. The concentration of free ADP in the 
cytosol is probably maintained within the opera- 
tional Km region for the adenine nucleotide trans- 
locator because of binding to actin and other pro- 
teins and by chelation with Mg’+. An increased 
ADP concentration in the cytosol will thus stimulate 
ADP entry into mitochondria in exchange with ATP 
from the mitochondrial matrix in an attempt to 
re-establish the extramitochondrial ATP/ADP ratio 
[84], while the intramitochondrial ATP/ADP ratio is 
maintained relatively constant by the activity of the 
mitochondrial ATPase. Since the proton electro- 
chemical gradient (A&+) provides a back pressure to 
the transport of electrons through the respiratory 
chain and is considered the energy-transducing inter- 
mediate between oxidation and phosphorylation, the 
fall of the intramitochondrial phosphorylation poten- 
tial is accompanied by a fall of GH+. The near equi- 
librium relationship between AE, and Aj&+ is thus 
disturbed and the rate of NADH oxidation by NADH 
dehydrogenase is increased, which results in an oxida- 
tion of the NADH/NAD’ couple. As already dis- 
cussed, the mitochondrial NAD’-linked substrate 
dehydrogenases are mostly irreversible enzymes that 
are kinetically regulated by the NADH/NAD’ ratio. 
Hence, each steady state increase of flux is associated 
with a new, more oxidized NAD+ redox potential as 
determined by the nature of the substrate supply and 
the sensitivity of the individual dehydrogenases to 
kinetic regulation by the NADH/NAD+ ratio. Increased 
electron transport causes a reduction of cytochrome c 
despite a contraction in the aEn redox span from 
NADH to cytochrome c [85,86], which is important 
in the regulation of the cytochrome oxidase complex 
[87,88]. In summary, when respiration changes, the 
primary control signal is the cytosolic ATP/ADP 
ratio; this transmits its effects via changes of the 
transmembrane proton electrochemical potential and 
the mitochondrial NAD+/NADH ratio to the respira- 
tory carriers and the substrate dehydrogenases, whose 
activity is thereby regulated secondarily to phosphate 
acceptor control of electron transport (further dis- 
cussed in [15,16]). 
5. Effects of Ca2+ on the activities of intramitochon- 
drial enzymes 
Considerable evidence suggests that Ca2+ plays a 
key role in controlling many biological functions and 
that mitochondria, which contain a high proportion 
of the total cellular calcium, may be crucially impor- 
tant in the control of intracellular Ca2+ homeostasis 
(reviewed [89,90]). Three mammaiian mitochondrial 
dehydrogenases: the pyruvate dehydrogenase com- 
plex, NAD’-linked isocitrate dehydrogenase, and the 
a-ketoglutarate dehydrogenase complex, have been 
shown to be activated by Ca2+ [ 18,22,9 I], while Ca2+ 
has been shown to inhibit the activities of pyruvate 
carboxylase [92,93] and carbamyl-phosphate syn- 
thase [94]. 
The pyruvate dehydrogenase complex (PDH) 
catalyses the irreversible oxidation of pyruvate to 
acetyl-CoA according to the reaction: 
Pyruvate + NAD+ + CoASH + acetylCoA + NADH + CO, 
In heart muscle, essentially all the acetyl-CoA formed 
from pyruvate is oxidized via the citric acid cycle 
whereas in other tissues such as liver and adipose tis- 
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Fig.2. Mechanisms of regulation of pyruvate dehydrogenase 
by end-product inhibition and by phosphorylation-dephos- 
phorylation, and their interrelation. 
sue, a substantial proportion of the acetyl-CoA is uti- 
lized for the biosynthesis of fatty acids and sterols. 
Pyruvate dehydrogenase is thus involved in both bio-. 
energetic and biosynthetic pathways and it is there- 
fore not surprising that the complex is subject to 
precise control by end-product inhibition and by a 
phosphorylation-dephosphorylation cycle, with 
interrelations between the two types of control 
(reviewed [4,18,95]. Fig.2 summarizes the regulatory 
properties of PDH; the reaction is inhibited (through 
end-product inhibition) by high ratios of acetyl-CoA/ 
CoASH and NADH/NAD’. In general, the principal 
substrates for the PDH reaction are also inhibitors of 
the kinase reaction and the product inhibitors of the 
dehydrogenase reaction are also activators of the 
kinase reaction. Free Ca*+ has been shown to affect 
the interconversion of the active and inactive forms 
of pyruvate dehydrogenase; PDH phosphatase from a 
number of tissues requires Mg*+ and is activated by 
Ca*+ with Km about 0.7 I.~M [91], while the kinase 
is inhibited at >O. 1 PM Ca*+ [96]. However, a sub- 
stantially higher Km of Ca *+ for the phosphatase reac- 
tion has also been reported [97]. Most experiments 
studying the Ca*+ sensitivity of PDH have utilized 
Ca-EGTA buffers and relied on computed free Ca*+ 
concentrations. In the limited number of experiments 
where Ca*+-dependence was demonstrated without 
using Ca-EGTA buffers, substantially higher concen- 
trations of added Ca*+ were required to elicit effects 
on PDH kinase and phosphatase activities [9 1,961. 
The reason for this discrepancy has not been resolved, 
but might be related to artifacts induced by the pres- 
ence of EGTA through chelation of other ionic spe- 
cies. Studies with intact heart, liver and adipose tissue 
mitochondria have generally confirmed an activation 
of PDH by Ca *+. Depletion of calcium from isolated 
mitochondria by addition of the Ca*+-ionophore, 
A-23187, led to inactivation of PDH phosphatase, 
which could be reversed by the addition of both Mg*+ 
and Ca*+ [98,99]. Upon varying the extramitochon- 
drial Ca*+ by the use of Ca-EGTA buffers the [Ca”] 
required for half-maximal effect on PDH was found 
to be <l PM [lOO,lOl]. 
The proportion of active (non-phosphorylated) 
pyruvate dehydrogenase is decreased by starvation 
and by alloxan-diabetes in heart, skeletal muscle, 
liver, kidney and adipose tissue [102-1061 with no 
change in the total activity. This effect could not be 
explained by changes of the acetyl-CoA/CoASH or 
NAD’/NADH ratios. Studies with mitochondria or 
extracts from alloxan-diabetic or starved animals 
showed that the kinase activity was insensitive to inhi- 
bition by pyruvate and that there was an apparent 
inhibition of phosphatase activity due to a change in 
Km of the PDH substrate for the phosphatase [104, 
107,108]. It has been suggested that in the rat, diabetes 
and starvation are associated with multi-site phoshor- 
ylation of the decarboxylase tetramer (02Psf12) of 
PDH [107,108]. In addition, the effect of phosphoryla- 
tion at sites 2 and 3 on phosphatase is to cause about a 
3-fold increase in the apparent Km for Ca*+, sug- 
gesting a possible link with Ca*+ in these metabolic 
states [97]. 
The activity of NAD+-linked isocitrate dehydro- 
genase has recently been shown to be activated by 
Ca*+ with a half-maximal effect at about 1 PM [ 1091. 
The reported inhibition by Ca*+ of the enzyme from 
rat heart [ 1 lo] has been attributed to the removal 
of Mn*+, which is obligatory for enzyme activity, by 
the EGTA in the Ca-EGTA buffer [ 1091. The effects 
of Ca*+ on NAD’linked isocitrate dehydrogenase are 
only observed in the presence of ADP [ 1091; it is pos- 
sible that the effect of Ca*+ may be related to the 
reported association of the enzymically active 330 000 
mol. wt protomer in the presence of ADP to dimeric 
and tetrameric forms [ 111 ,I 121. No effects of Ca*+ 
were observed on the activity of mitochondrial NADP’- 
linked isocitrate dehydrogenase [1091. In an attempt 
to demonstrate the Ca*+-sensitivity of NAD+-linked 
isocitrate dehydrogenase with intact mitochondria, 
K79 
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McCormack and Denton [ 1131 examined the effects 
of changes in extramitochondrial Ca*+ (using Ca-EGTA 
buffers) on the oxidation of threu-D,-isocitrate in 
uncoupled mitochondria from brown adipose tissue. 
The half maximal concentration required for Ca*+ acti- 
vation was 1.6 PM, and Ca*+ lowered the apparent Km 
for isocitrate about 3-fold. Nevertheless, the elevated 
concentrations of mitochondrial ATP in the uncou- 
pled state are such as to favour the Ca*+-dependence 
of the enzyme. 
ar_Ketoglutarate dehydrogenase from heart and 
kidney is also activated by Ca*+ in the 1 FM range 
based on Ca-EGTA buffers; in the absence of NADH, 
Ca*+ caused a decrease of the apparent Km for a-keto- 
glutarate [22,71]. In the presence of NADH, Ca*+ 
decreased the NADH inhibition of ar-ketoglutarate 
dehydrogenase, and produced a 20-fold increase in 
the activity of a-ketoglutarate dehydrogenase over 
1 O-‘-l Om5 M Ca*+, whereas in the absence of NADH 
there was only a 2-fold increase [71]. The apparent 
Km for a-ketoglutarate is increased by ATP and 
decreased by ADP [22,71]. These effects appear to 
be independent of the Ca*+ effect on the apparent 
Km for a-ketoglutarate. However, in experiments 
where the ATP/ADP ratio was altered, the effect of 
Ca*+ on the NADH inhibition was considerably dimin- 
ished; as the ATP/ADP ratio decreased, the NADH 
inhibition became less sensitive to the presence or 
absence of Ca*+ [71]. It is of interest to note that 
although increased Ca*+ promotes flux through both 
pyruvate and a-ketoglutarate dehydrogenases, this 
effect is achieved by different mechanisms. In the 
case of pyruvate dehydrogenase the activation by 
Ca*+ appears to be mediated by lowering the Km of 
the phosphorylated enzyme for the phosphatase and 
also by inhibiting the kinase, thereby increasing the 
proportion of enzyme in the active form. In contrast 
the effect of Ca*+ on a-ketoglutarate dehydrogenase 
appears to be mediated by a decrease in the apparent 
Km for a-ketoglutarate and, perhaps more signifi- 
cantly by decreasing the NADH inhibition of the 
enzyme. Certainly the effects of Ca*+ activation, 
mediated through effects on interconverting enzymes 
(kinase/phosphatase of pyruvate dehydrogenase), or 
binding of effecters (ADP to isocitrate dehydrogenase; 
NADH to a-ketoglutarate dehydrogenase) offers an 
interesting possibility for effecting a concerted regu- 
lation of flux through the citric acid cycle. As dis- 
cussed in the following sections, the critical factor is 
whether the mitochondrial free Ca*+ is normally in 
K80 
the correct range for regulation, and whether it 
changes under different metabolic conditions in a 
manner to account for alterations of citric acid cycle 
activity. 
By comparison with the dehydrogenases, the effects 
of Ca*+ on carbamyl phosphate synthetase and pyr- 
uvate carboxylase are less well documented. In rat 
liver mitochondria, citrulline synthesis is stimulated 
by EGTA and strongly inhibited by addition of low 
[Ca”] [94]. Further studies showed that the inhibi- 
tion of carbamyl-phosphate synthetase by Ca*+ 
occurred over the range of physiological mitochon- 
drial calcium contents and could be counteracted by 
increased Mg*+ (A. J. Meijer and J. R. Williamson, 
unpublished). However, the mechanism of the Ca*+ 
inhibition remains to be established; it appears to be 
independent of changes of N-acetylglutamate, an 
obligatory activator of carbamyl-phosphate synthe- 
tase. In many respects the regulation of carbamyl- 
phosphate synthetase resembles that of pyruvate car- 
boxylase; both enzymes require specific allosteric 
activators (iV-acetyl-glutamate and acetyl-CoA, 
respectively), MgATP and free Mg*+ for activation 
and are inhibited by Ca*+, competitive with Mg*+. 
Recent studies with isolated liver mitochondria have 
indicated that low concentrations of Ca*+ inhibited 
pyruvate carboxylation under conditions where there 
was no change in the intramitochondrial ATP, ADP 
or acetyl-CoA levels but a concomitant increase in 
the proportion of active pyruvate dehydrogenase 
[ 1141. Depletion of mitochondrial Ca*+ would thus 
be expected to stimulate both urea synthesis and 
gluconeogenesis. 
6. Regulation of intramitochondrial Ca*+ homeostasis 
Cells generally contain l-2 pm01 total calcium/g 
wet wt, most of which is sequestered in the intracel- 
lular organelles. Rapid disruption techniques applied 
to isolated hepatocytes have shown that 60-80% of 
the total calcium is in the mitochondria with most of 
the remainder being associated with the endoplasmic 
reticulum [25]. The cytosolic free Ca*+ of cells in the 
unstimulated state has generally been assumed to be 
10-7-10-6 M, largely on the basis of the known 
threshold values for stimulation of Ca*+-sensitive 
enzymes, Ca*+-binding proteins or Ca*+-sensitive meta- 
bolic or physiological functions of cells with a disrupted 
plasma membrane [ 115-l 171. Recent direct mea- 
Volume 117, Supplement 
surements of cytosolic free Ca2+ in squid axon [ 1181, 
muscle [ 118- 12 1 ] and isolated hepatocytes [25] 
have provided values of 40-200 nM under control 
conditions and have indicated that the increase fol- 
lowing stimulation is relatively modest (<5-fold). 
The mechanisms of Ca2+ transport by isolated 
mitochondria have recently been defined (reviewed 
[90,123]). Uptake and efflux of Ca2+ occurs by two 
separate and independent systems. Calcium uptake 
occurs by the electrophoretic transport of Ca*+ down 
the electrochemical gradient generated by the elec- 
trogenic efflux of protons produced by flux through 
the electron-transport chain, as illustrated in fig.3. 
The translocator has a high Vmax and Km 2-20 PM, 
depending on the mitochondrial species; the presence 
of Mg2+ increases the apparent Km. Calcium efflux 
occurs by an electroneutral exchange of Ca2+ with 
H+ or Na’ [90,124-1261. The Vmax for Ca2+ efflux 
is much lower than that for Ca2+ influx, while the 
out In 
2H+ ( 2H+ 
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Co*+ 
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Fig.3. Schematic representation f mitochondrial Ca*+-trans- 
port involving: (a) electrophoretic influx down the proton 
electrochemical gradient; and (b) Ca”+-efflux by electroneu- 
tral exchange with H’ or Na+. 
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apparent Km is higher [127]. Isolated mitochondria 
have been shown to buffer the external free Ca2+ con- 
centration, which remains approximately constant 
under defined conditions of Mg2+, Na’ and energy 
state as a result of net uptake or release of mitochon- 
drial calcium until influx and efflux rates become 
equal. At equilibrium, a free [Ca2’] of 0.8 PM has been 
observed with liver mitochondria, which was increased 
by addition of 1 mM Mg*+ [ 1281, while with heart 
mitochondria, 0.2 PM and 1.4 PM were observed in 
the absence and presence of 5 mM Na’ [ 1251. The 
simultaneous operation of independent uptake and 
efflux pathways across the inner membrane results in 
a continuous cycling of Ca2+ between the cytosolic 
and matrix components, which is thus associated with 
a continuous, albeit small, dissipation of Aj&+. 
On a thermodynamic basis, according to the 
Nernst equation: 
A$= 
a 10’ gradient of Ca2* across the inner mitochondrial 
membrane would be predicted at equilibrium for A$ 
150 mV. However, it is evident that Ca2+ gradients of 
this magnitude are not attained by isolated mitochon- 
dria. A study of the relationship between extramito- 
chondrial free Ca2+ and Ca2+ accumulated in the 
matrix indicated a biphasic relationship; the extra- 
mitochondrial Ca2+ was almost independent of the 
Ca2+ accumulated in the matrix up to about 50 nmol 
Ca**/mg protein but further accumulation was asso- 
ciated with a rise in the extracellular Ca*+ [ 1281. 
Direct measurements of the mitochondrial free 
[Ca”] have yielded 64 f 2 PM for liver mitochondria 
containing 10 nmol total calcium/mg protein [ 1271. 
Measurement of the total mitochondrial Ca2+ fol- 
lowing rapid disruption of isolated hepatocytes pro- 
vided a similar value of 9.8 nmol calcium/mg mito- 
chondrial protein [25]. Furthermore, studies on the 
relationship between the total calcium content of 
mitochondria and the free [Ca”] achieved by cal- 
cium loading of the mitochondria, indicated a linear 
relationship between free Ca2+ versus total calcium 
over lo-36 nmol/mg mitochondrial protein with a 
slope of 0.004 [ 1271. Mitochondrial free Ca2+ at 
64 PM and cytosolic free Ca*+ at 0.2 PM [25] implies 
a gradient of free Ca2+ across the mitochondrial 
membrane in the hepatocyte of 320, which corre- 
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sponds to a AJ, of 75 mV according to the Nernst 
equation. This value may be compared with about 
80 mV for AJ, obtained by Nicholls [ 1281 below 
which liver mitochondria were unable to maintain 
extramitochondrial steady state free Ca’+ at 0.8 MM, 
as A$ was decreased by increasing the [K’] in the 
presence of valinomycin. These and earlier data 
[129,130] suggest hat the gradient of free Ca’+ 
across the mitochondrial membrane is in equilibrium 
with the membrane potential up to 70-80 mV and 
thereafter becomes independent. The agreement 
between the numbers generally supports the validity 
of the directly measured Ca*+ gradient. However, the 
measurement of the matrix free [Ca*‘] relies on a 
determination of the medium free [Ca”] at the null 
point, when Ca*+ movements across the mitochon- 
drial membrane are zero in the presence of ionophore 
A-23 187, and assumes that there is no [Ca”] gra- 
dient under these conditions. This assumption is sup- 
ported by the lack of effect of nigericin (added to 
promote collapse of the ApH) on the measured Ca*+ 
null point values, and a negligible ApH calculated 
from the distribution of [14C]DM0 (5,5’-dimethyl- 
oxazolidine-2,4-dione). Nonetheless, a residual ApH 
of 0.15 units would correspond to a 2-fold Ca*+ gra- 
dient, but it is unlikely that corrected matrix free 
Ca*+ would be <30 PM. 
7. Physiological significance of intramitochondrii 
Ca*+ in relation to activity of the citric acid cycle 
In attempting to assess whether intramitochondrial 
Ca*+ is likely to play a role in mediating flux through 
the citric acid cycle, the intramitochondrial [Ca*‘] 
relative to the Ca*+-sensitivity of the particular 
enzymes is clearly of paramount importance. Matrix 
free Ca*+ at about 60 PM obtained with isolated liver 
mitochondria [2.5,127] is considerably higher than 
the reported Ca*+-sensitivity range of isolated NAD+- 
linked isocitrate dehydrogenase, cr-ketoglutarate 
dehydrogenase and pyruvate dehydrogenase, although 
in the latter case there is evidence to suggest hat 
under certain circumstances the Ca*+ sensitivity might 
be in a range favourable for kinetic control through 
changes in intramitochondrial free Ca*+. Certainly in 
the case of NAD’-linked isocitrate dehydrogenase and 
a-ketoglutarate dehydrogenase, further studies are 
warranted to establish fully the range of Ca*+ over 
which the enzymes respond; the studies with Ca-EGTA 
buffers certainly do not rule out the possibility that 
EGTA itself may affect the Ca*+-sensitivity. The stud- 
ies on the effect of changes in extramitochondrial 
Ca*+ on the activities of pyruvate dehydrogenase, 
NAD’-linked isocitrate dehydrogenase and o-keto- 
glutarate dehydrogenase in uncoupled mitochondria 
[ 101 ,113] also do not provide reliable indications of 
changes in intramitochondrial Ca*+ to which the 
enzymes may be responding, since it is possible that 
under the conditions of the experiments a gradient of 
free Ca*+ across the inner mitochondrial membrane 
determined by a residual membrane potential (A@) 
could still exist; a contribution of 30 mV could lead 
to a lo-fold gradient. 
It is pertinent to consider whether changes in 
intramitochondrial Ca*+ can be correlated with 
changes in citric acid cycle flux. Unfortunately, the 
available data are contradictory. The best docu- 
mented hormone-induced effects on hepatic calcium 
homeostasis are those mediated by cu-adrenergic 
agents and vasopressin, which cause a fall of mito- 
chondrial total [23-251 and free calcium (J. R. 
Williamson, unpublished). This effect might account 
for the observed stimulation of pyruvate carboxyla- 
tion with phenylephrine [ 13 l] as a result of a dimin- 
ished inhibition of pyruvate carboxylase by Ca*+, but 
is inconsistent with a Ca*+-mediated regulation of 
citric acid cycle activity, which increases despite a fall 
of mitochondrial Ca*+. Furthermore, vasopressin 
effects on liver include an activation of pyruvate 
dehydrogenase [1321, rather than an inhibition pre- 
dicted from the lowered mitochondrial Ca*+. On the 
other hand, glucagon stimulates gluconeogenesis and 
citric acid cycle activity, but apparently has no effect 
on cytosolic free Ca*+ [25] or mitochondrial Ca*+ 
[ 1251. Whether the increased activity of pyruvate 
dehydrogenase and citric acid cycle flux associated 
with increased work load in heart and gastrocnemius 
muscle [103,133,134] is in any way associated with 
changes in mitochondrial Ca*+ levels remains, for the 
moment, purely speculative. It has been reported that 
increased oxidation of intramitochondrial pyridine 
nucleotides induces a net efflux of Ca*+ from liver 
mitochondria [ 135,136]; it is therefore possible that 
the oxidation of pyridine nucleotides associated with 
conditions of increased work load may actually lead 
to a lowering of mitochondrial free Ca*+. Certainly 
before definitive statements can be made as to 
whether Ca*+ may provide another locus of control 
for the citric acid cycle, interrelated with the well- 
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documented feedback regulation by NAD’/NADH, a 
more comprehensive study of the intramitochondrial 
Ca2+-levels, under a variety of metabolic and hor- 
monal states, is required. The limited evidence avail- 
able at present pointing to a disparity between intra- 
mitochondrial Ca’+-levels and the Ca2+-sensitivity of 
enzymes of the citric acid cycle would tend to argue 
against such a regulatory role, although regulation of 
pyruvate dehydrogenase, pyruvate carboxylase and 
carbamyl phosphate synthetase activities by Ca2+ 
remains a distinct possibility. Our present conclusion 
on the basis of available evidence is that the mito- 
chondrial free Ca2+ is likely to be always in the range 
to saturate isocitrate and ar-ketoglutarate dehydro- 
genases, and that Ca2+ binding serves the purpose of 
modulating the inhibitory effects of high NADH/ 
NAD’ and ATP/ADP ratios. 
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